CDT Equity (CDT) Change in Cash (2022 - 2026)
CDT Equity's (CDT) quarterly Change in Cash came in at -$1.4 million in Q1 2026, down 189.59% YoY from $1.6 million in Q1 2025, and up 39.37% on a QoQ basis from -$2.3 million in Q4 2025.
CDT Equity (CDT) Change in Cash (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Change in Cash data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Change in Cash fell 189.59% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 773.18% YoY) and the FY2025 annual result came in at $955000.0, up 126.11% from the prior year.
- Change in Cash improved to -$1.4 million in Q1 2026, from -$2.3 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $8.7 million in Q3 2023 to a low of -$4.4 million in Q4 2023.
- A 5-year average of $6588.2 and a median of -$109615.0 in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash jumped 7995.82% — and 2024, when it slumped 29900.0%.
- Tracing CDT's Change in Cash over 5 years: stood at -$680517.0 in 2022, then slumped by 549.65% to -$4.4 million in 2023, then surged by 111.29% to $499000.0 in 2024, then tumbled by 566.73% to -$2.3 million in 2025, then soared by 39.37% to -$1.4 million in 2026.
- The last three Change in Cash figures came in at -$1.4 million (Q1 2026), -$2.3 million (Q4 2025), and $506000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 648,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 648,000.00 |
| Mar 31, 2026 | -1.41 Mn |
| Dec 31, 2025 | -2.33 Mn |
| Sep 30, 2025 | 506,000.00 |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 499,000.00 |
| Sep 30, 2024 | -148,000.00 |
| Jun 30, 2024 | -1.63 Mn |
| Mar 31, 2024 | -2.38 Mn |
| Dec 31, 2023 | -4.42 Mn |
| Sep 30, 2023 | 8.66 Mn |
| Jun 30, 2023 | -14,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | -680,517.00 |
| Sep 30, 2022 | -109,615.00 |
| Jun 30, 2022 | -126,915.00 |
| Mar 31, 2022 | 916,047.00 |